Rajeev M. Shah

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas P. O'Neil as Attorney in Fact for Rajeev M. Shah
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Rajeev M. Shah

Form 4 holding Director

Kala Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
10,894,613
Estimated value
$73,429,692
Report date
17 Jun 2021
Price
$6.74
Ownership
Indirect
Form 4 holding 10%+ Owner

Solid Biosciences Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
30,000
Estimated value
Report date
16 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Black Diamond Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,500
Estimated value
Report date
16 May 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Satsuma Pharmaceuticals, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
0
Estimated value
Report date
06 Jun 2023
Price
$0.9100
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Rajeev M. Shah

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .